Short Interest in China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Declines By 54.8%

China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) saw a significant decline in short interest during the month of March. As of March 15th, there was short interest totalling 32,900 shares, a decline of 54.8% from the February 28th total of 72,800 shares. Based on an average trading volume of 127,900 shares, the short-interest ratio is presently 0.3 days. Approximately 0.2% of the shares of the stock are short sold.

China SXT Pharmaceuticals Trading Up 2.2 %

Shares of SXTC traded up $0.06 during mid-day trading on Friday, reaching $2.78. 14,711 shares of the company’s stock were exchanged, compared to its average volume of 123,601. China SXT Pharmaceuticals has a 52-week low of $2.40 and a 52-week high of $26.96. The company has a 50-day simple moving average of $3.42 and a two-hundred day simple moving average of $3.85.

About China SXT Pharmaceuticals

China SXT Pharmaceuticals, Inc, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.